Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor ...

What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...